Rosa's Brian Schneider and Matt Marano will run a Roundtable at the event on November 9, 2023 in Cambridge, Massachusetts, USA. More information is available at https://proventainternational....

Come talk with Rosa at the MarcusEvans Evolution Summit on September 11-13, 2023 at the Park Hyatt Aviara Resort, Golf Club & Spa , Carlsbad, CA.
https://www.sept23.evolutionsu...

Rosa & Co is pleased to announce the publication of "Using machine learning surrogate modeling for faster QSP VP cohort generation" which was published in CPT:PSP. The article is available at https://ascpt.onlinelibrary.wi...

Rosa & Co is pleased to announce that it will be presenting two posters at the Population Approach Group Europe (PAGE) 2023 meeting.
Poster II-31 'Incorporating complex drug PK with multiple binding targets into a QSP model to predict combined PD effects.' will be presented by Jared Cui on Wednesday, June 28 from 15:35-17:00. https://www.page-meeting.org/d...
Poster II-63 'Development of a primary Sjogren’s Syndrome (pSS) quantitative systems pharmacology (QSP) model linking mechanistic pathways to clinical scores.' will be presented by Vincent Hurez on Wednesday, June 28 from 15:35-17:00. https://www.page-meeting.org/d...,

Matt Marano, Chief Commercial Officer of Rosa & Co,. and Brian Schneider, Vice President of Business Development for Rosa & Co., will be attending the MarcusEvans Evolution Summit on May 24-26, 2023, at the Encore Boston Harbor in Boston, MA. https://may23.evolutionsummit.com

Rosa & Co. announced today the publication of an article titled, “From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology (QSP) Modeling in Cancer Immunotherapy,” which was published in Clinical Pharmacology & Therapeutics. To read the article see: https://ascpt.onlinelibrary.wi...

Meet with Rob Singer and Matt Marano from Rosa & Co. at the MarcusEvans PharmaMarketing Summit in Westlake Village, CA on May 11-12, 2023, to learn more about Rosa’s ForecastMD® Market Modeling Platform and DueDiligenceMD™ offering. For more information about the Summit, see https://www.may23.pharmamarketingsummit.com/

Meet with Matt Marano, Chief Commercial Officer for Rosa & Co and Mike Reed, PhD, Chief Scientist for Rosa’s PhysioPD® QSP Platform at Proventa’s 5th Annual Clinical Operations Strategy Meeting in San Diego on May 11, 2023.

Mike will be giving a Keynote Presentation titled, “The Growth of Modeling and Simulation Strategies in Pharmaceutical Research, Development and Clinical Programs.”

For more information see, https://proventainternational.com/events/clinical/usa-west/san-diego/clinical-operations-strategy-meeting-west-coast-2023/

Rosa's Christina Friedrich will be on the panel for FDA workshop 'Creating a Roadmap to Quantitative Systems Pharmacology Informed Rare-Disease Drug Development. May 11, 2023. For more information about the workshop, see https://cersi.umd.edu/event/17946/creating-a-roadmap-to-quantitative-systems-pharmacology-informed-rare--disease-drug-development.

Meet with Matt Marano, Chief Commercial Officer of Rosa & Co., to learn
more about Rosa’s PhysioPD® Research Platforms at the MarcusEvans
Evolution Summit in Montreux, Switzerland, on April 20-21, 2023. For more information about the summit, see https://www.april23.evolution-summit.com/

Meet with Rob Singer of Rosa Market Modeling at the Biotechgate Digital Partnering Meeting from February 6-10, 2023. For more information about the event, see https://partnering.biotechgate.com/.

Rosa is seeking PhD students, postdoctoral scholars, and early researchers in academia & industry to present as part of the Rosa World Wide Webinar series. These webinars will support outstanding early career investigators by providing an opportunity for them to show their research to a broad audience. We are looking for presenters whose research advances the adoption of modeling and simulation in drug development.

If you are an early career investigator with an interesting research presentation, please send a title, abstract, and a short bio to webinar@rosaandco.com.

Rosa has been hosting the monthly “Impact” webinar series since 2011 and each Webinar draws several hundred attendees from a mix of drug development disciplines. The speakers and audience come from both industry and academia. Each Webinar includes a slide presentation followed by a brief discussion, lasting about an hour total. After the webinar, a recording of the webinar and slides from the webinar are posted on the webinar archive site. For your reference, you can see archived sessions and the upcoming Webinar schedule here: http://www.rosaandco.com/webinars.

Deadline to apply to present as an early career investigator is April 1, 2023.

Rosa will be participating in the Biotechgate Digital Partnering Meeting. Meet with Rob Singer of Rosa Market Modeling at the Digital Partnering Meeting from November 28 to December 2, 2022. For more information on the event, pleas see the websites at https://partnering.biotechgate.com/login/index/BDP1122 and https://www.digitalpartnering.com/.

Rosa & Co. announced today the publication of an article titled, “Quantitative Systems Pharmacology Model of the Amyloid Pathway in Alzheimer’s Disease: Insights into the Therapeutic Mechanisms of Clinical Candidates,” which was published online ahead of print on CPT Pharmacometrics Syst Pharmacol. on October 24, 2022. To read the article: https://ascpt.onlinelibrary.wi...

Rosa & Co. is pleased to announce the presentation of two posters at the 2022 ACoP13 meeting. The posters ‘QSP Model of Aß Accumulation Predicts Different Treatment Effects at Different Stages of Alzheimer’s Disease.’ and ‘Higher Fentanyl Exposures Require Higher Doses of Naloxone for Successful Reversals in a Quantitative Systems Pharmacology Model.’ will be presented on October 31 at the the ACoP13 meeting in Aurora Colorado. For more information about the meeting, see https://www.go-acop.org/.

Matt Marano, Chief Commercial Officer for Rosa & Co. will be attending the upcoming Cell and Gene Therapy Strategy Meeting: Europe 2022 on Tuesday, October 11, 2022. See the following link for more details. https://proventainternational.com/211-partner/

Meet with Matt Marano, Chief Commercial Officer for Rosa & Co. at the upcoming Proventa Clinical Operations Strategy Meeting in Zurich on Monday, October 10, 2022. Click the link for more details.

Meet with Rob Singer from Rosa & Co. at Biopharm America, Oct 4-5, 2022. https://buff.ly/3V0T5rd. Rob will be speaking with biotech and pharmaceutical companies about Rosa’s ForecastMD™ Platform and to investors about Rosa’s new DueDiligenceMD service. This will be a virtual meeting.

Rosa & Co. is pleased to announce it is offering DueDiligenceMD in addition to the ForecastMD™ Research Platform. For organizations that are evaluating assets for in-licensing, partnering, or acquisition, DueDiligenceMD quantifies and explains the expected physician demand for the asset, based on primary market research and an Excel®-based Revenue Model. DueDiligenceMD projects are typically completed within two weeks.

Rosa & Co. is also enhancing our PhysioPD® Research with the use of Artificial Intelligence/ Machine Learning (AI/ML) techniques. PhysioPD Research provides biological context, facilitates insight into dynamics and causality, and supports hypothesis generation. Adding AI/ML techniques to PhysioPD Research speeds the identification of networks from data, supports empirical model and Virtual Patient creation, and enriches the insights extracted from simulation results.

See the press release at https://www.einnews.com/pr_new...

Rosa & Co. LLC is pleased to announce that Dr. Bill Brastow, Chief Technology Officer for Rosa Market Modeling, will present a webinar "Injecting Reality into Commercial Due Diligence for In-Licensing, Partnering or Purchasing Pharmaceutical Assets in Development" on Wednesday, August 17, 2022, at 12:00 to 1:00 pm EDT.

As part of the Rosa World-Wide Webinar Series, this webinar focuses on how pharmaceutical and biotech companies can inject reality into the commercial opportunity analysis by measuring expected physician demand for the drug to inform revenue projections and decisions about in-licensing, partnering, or purchasing these assets.

To learn more or register for the webinar, see: https://rosaandco.com/webinars